InsiderTrades

Form 4 for SNPS Synopsys

Accepted 2024-01-04 00:00:00 ET · period of report 2024-01-03 · accession 0001517737-24-000006 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-01-04 2024-01-03 SNPS MAHONEY RICHARD S. Chief Revenue Off M - OptEx $319.20 +4,424 10.7K +71% +$1.41M
DM 2024-01-04 2024-01-03 SNPS MAHONEY RICHARD S. Chief Revenue Off S - Sale+OE $494.70 -9,065 1,617 -85% -$4.48M
D 2024-01-04 2024-01-03 SNPS MAHONEY RICHARD S. Chief Revenue Off M - OptEx $0.00 -4,424 19.2K -19% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-01-03 M A 4,424 $319.20 10,682 D — —
2 Common Common Stock 2024-01-03 S D 4,424 $494.68 6,258 D — — (F1) Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $492.053 to $496.500. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range.
3 Common Common Stock 2024-01-03 S D 4,641 $494.72 1,617 D — — (F1) Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $492.053 to $496.500. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range.
4 Derivative Non-Qualified Stock Option (right to buy) 2024-01-03 M D 4,424 $0.00 19,169 D $319.20 · 2023-05-31 to 2029-05-31 4,424 Common Stock (F3) 1/4 of the grant becomes exercisable on the date shown with the remainder becoming exercisable in a series of 12 equal quarterly installments thereafter, subject to continued service through each vesting date.